Antibody-based validation of CNS ion channel drug targets
- PMID: 18411328
- PMCID: PMC2346570
- DOI: 10.1085/jgp.200709926
Antibody-based validation of CNS ion channel drug targets
Figures
References
-
- An, W.F., M.R. Bowlby, M. Betty, J. Cao, H.P. Ling, G. Mendoza, J.W. Hinson, K.I. Mattsson, B.W. Strassle, J.S. Trimmer, and K.J. Rhodes. 2000. Modulation of A-type potassium channels by a family of calcium sensors. Nature. 403:553–556. - PubMed
-
- Bagetta, G., G. Nistico, and J.O. Dolly. 1992. Production of seizures and brain damage in rats by α-dendrotoxin, a selective K+ channel blocker. Neurosci. Lett. 139:34–40. - PubMed
-
- Bekele-Arcuri, Z., M.F. Matos, L. Manganas, B.W. Strassle, M.M. Monaghan, K.J. Rhodes, and J.S. Trimmer. 1996. Generation and characterization of subtype-specific monoclonal antibodies to K+ channel α- and β-subunit polypeptides. Neuropharmacology. 35:851–865. - PubMed
-
- Bowlby, M.R., P. Chanda, W. Edris, J. Hinson, F. Jow, A.H. Katz, J. Kennedy, G. Krishnamurthy, K. Pitts, K. Ryan, et al. 2005. Identification and characterization of small molecule modulators of KChIP/Kv4 function. Bioorg. Med. Chem. 13:6112–6119. - PubMed
-
- Chandy, K.G., C.B. Williams, R.H. Spencer, B.A. Aguilar, S. Ghanshani, B.L. Tempel, and G.A. Gutman. 1990. A family of three mouse potassium channel genes with intronless coding regions. Science. 247:973–975. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
